Phenomenological and pharmacological identity of audiogenic-sensitive state in animals treated with methionine sulfoximine and in genetically audiogenic-seizure-susceptible animals.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004569:Electroencephalography; D004924:Escape Reaction / Q000187:drug effects*; D005260:Female; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008715:Methionine / Q000494:pharmacology*; D008717:Methionine Sulfoximine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012640:Seizures / Q000139:chemically induced*; D012701:Serotonin / Q000494:pharmacology; D013016:Sound
D008717:Methionine Sulfoximine; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D001285:Atropine; D012110:Reserpine; D010830:Physostigmine; D008715:Methionine; D007490:Iproniazid